The diagnosis of AME is usually suspected in the setting on non-aldosterone dependent LRH with classic features of MR activation and confirmed by a high cortisol/cortisone (F/E) ratio in the serum or urine, and/or genetic sequencing of 11βHSD2 [61,62]. This evidence concerns the gene NR3C2 and apparent mineralocorticoid excess.